Patent · US Active

Vaccine carrier

US9296828B2 · kind B2 · utility

1Cited by
0References
21Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 11, 2007
Grant dateMar 29, 2016
Priority date
Expiry dateApr 10, 2028

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2770/32734
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to a hypoallergenic protein consisting of at least one hypoallergenic molecule derived from an allergen, which is fused or conjugated to at least one second non-allergenic protein or fragment thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.